Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion
SARS-CoV-2 in patients who need intensive care unit (ICU) is associated with a mortality rate ranging from 10 to 40–45%, with an increase in morbidity and mortality in presence of sepsis. We hypothesized that IgM and IgA enriched immunoglobulin G may support the sepsis-related phase improving patien...
Main Authors: | Alberto Corona, Giuseppe Richini, Sara Simoncini, Marta Zangrandi, Monica Biasini, Giuseppe Russo, Mauro Pasqua, Clemente Santorsola, Camilla Gregorini, Chiara Giordano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/930 |
Similar Items
-
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
by: Olayinka M. Olajiga, et al.
Published: (2022-10-01) -
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
by: Lippi Giuseppe, et al.
Published: (2023-03-01) -
Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
by: Maciej Tota, et al.
Published: (2023-04-01) -
IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices
by: Moritz Benjamin Immohr, et al.
Published: (2022-10-01) -
Plasmodium falciparum coinfection is associated with improved IgE and IgG3 response against hookworm antigens
by: Samuel A. Sakyi, et al.
Published: (2022-07-01)